Protein-S Test for Thrombophilia at Lahore PCR Lab

Protein-S at Lahore PCR Lab

The Protein-S test is a highly specialized coagulation analysis performed to evaluate a patient’s risk of developing abnormal blood clots. Protein S is a vital, vitamin K-dependent plasma glycoprotein synthesized primarily in the liver. It plays a critical role in the natural anticoagulant system of the human body by serving as a non-enzymatic cofactor for Activated Protein C (APC). Together, the Activated Protein C-Protein S complex selectively degrades and inactivates coagulation Factors Va and VIIIa. This inactivation is a key regulatory step that limits thrombin generation and prevents excessive, life-threatening blood clot formation within the vascular system. When a patient has a deficiency or dysfunction of Protein S, this natural brake on the coagulation cascade is compromised, leading to a state of hypercoagulability or thrombophilia. This significantly increases the clinical risk of venous thromboembolism, including deep vein thrombosis and pulmonary embolism.

At Lahore PCR Lab, located in Lahore, Pakistan, we utilize advanced automated coagulation analyzers to perform precise Protein-S assays. The test measures either the functional activity of Protein S or the physical quantity of the protein (antigen levels). In the bloodstream, Protein S exists in two distinct forms: a free active form, which constitutes about 30 to 40 percent of the total protein, and an inactive form bound to C4b-binding protein (C4b-BP), which makes up the remaining 60 to 70 percent. Because only the free form can act as a cofactor for Activated Protein C, measuring free Protein S antigen and functional activity is of paramount diagnostic value. Our state-of-the-art laboratory infrastructure and stringent quality control protocols ensure that patients and referring physicians receive highly reliable results, which are essential for diagnosing hereditary or acquired thrombophilia, guiding long-term anticoagulation therapy, and managing complex cardiovascular and hematological conditions.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is critical for ensuring the accuracy of a Protein-S test, as numerous physiological factors, medications, and clinical states can temporarily alter Protein S levels and lead to misleading results. Patients must strictly adhere to the following preparation guidelines:

• Medication Review: Inform your prescribing physician and the laboratory staff at Lahore PCR Lab of all medications you are currently taking. Oral anticoagulants, particularly vitamin K antagonists like Warfarin, significantly lower Protein S levels. Patients are typically required to discontinue Warfarin for at least two weeks before testing, under strict medical supervision. Direct Oral Anticoagulants (DOACs) such as Rivaroxaban, Apixaban, and Dabigatran, as well as Heparin therapy, can also interfere with functional clotting assays and must be managed appropriately prior to sample collection.
• Timing of the Test: The Protein-S test should not be performed during an acute thrombotic event (such as an active deep vein thrombosis or pulmonary embolism) or within four to six weeks following the event. Acute clotting consumes natural anticoagulants, leading to transiently low levels that do not reflect the patient’s true baseline.
• Hormonal Influences: Estrogen-containing medications, including oral contraceptive pills and hormone replacement therapy (HRT), naturally decrease Protein S levels. If testing for an inherited deficiency, these medications should ideally be discontinued for several weeks prior to the blood draw, in consultation with your doctor.
• Pregnancy Considerations: Protein S levels physiologically decrease during pregnancy. To evaluate for a hereditary deficiency, testing should be postponed until at least six to twelve weeks postpartum.
• Fasting and Hydration: While strict fasting is generally not mandatory for an isolated Protein-S test, maintaining adequate hydration by drinking plenty of water is recommended to facilitate venipuncture. If other concurrent blood tests are ordered, fasting may be required.

During the Procedure

The collection of a blood sample for a Protein-S test at Lahore PCR Lab is a quick, safe, and standardized procedure performed by our experienced phlebotomists. The process involves the following steps:

• Patient Identification and Positioning: The phlebotomist will verify your identity and explain the procedure. You will be seated comfortably in a blood collection chair with your arm extended and supported.
• Vein Selection and Sanitization: The phlebotomist will inspect your arm, typically the antecubital fossa (the crease of the elbow), to locate a suitable, healthy vein. The selected site is then thoroughly sanitized with an antiseptic swab (isopropyl alcohol) and allowed to air dry to prevent specimen contamination.
• Tourniquet Application: A soft elastic tourniquet is applied around your upper arm to increase venous pressure, making the vein more visible and accessible.
• Venipuncture: A sterile, single-use needle is gently inserted into the vein. You may feel a brief, minor pinch or prick. Blood is drawn directly into a specialized light blue-top tube containing sodium citrate. The sodium citrate acts as an anticoagulant that reversibly binds calcium, preserving the coagulation factors in the plasma for accurate laboratory analysis.
• Tube Filling and Mixing: It is clinically vital that the tube is filled completely to the designated mark to maintain the precise 9:1 ratio of blood to sodium citrate. An incorrect ratio can severely distort the test results. Once filled, the tube is gently inverted several times to mix the blood with the preservative.
• Needle Removal and Post-Care: The tourniquet is released, the needle is carefully withdrawn, and immediate pressure is applied to the puncture site with a sterile gauze pad to stop any bleeding. A small adhesive bandage is then applied. The entire process takes less than five minutes.

When is a Protein-S Test Performed?

Evaluation of Unexplained Venous Thromboembolism (VTE)

Physicians frequently request a Protein-S test when a patient experiences an unexplained or unprovoked blood clot, such as deep vein thrombosis in the leg or a pulmonary embolism in the lungs. This is especially critical if the event occurs in an individual under the age of 50, or if there is no obvious triggering factor like major surgery, severe trauma, or prolonged immobilization. Identifying a primary Protein S deficiency helps clinicians understand the underlying etiology of the clot and determine the appropriate duration and intensity of anticoagulant therapy to prevent life-threatening recurrences.

Investigation of Recurrent Pregnancy Loss

Recurrent miscarriage, defined as the loss of two or more consecutive pregnancies, is a deeply distressing clinical issue that warrants a thorough investigation. Inherited or acquired thrombophilias, including Protein S deficiency, can lead to microthrombi formation within the developing placental vasculature. This restricts essential blood flow, oxygen, and nutrient delivery to the fetus, potentially causing early pregnancy loss, late-term stillbirth, severe preeclampsia, or intrauterine growth restriction (IUGR). A Protein-S test helps identify women who may benefit from specialized thromboprophylaxis during future pregnancies.

Family Screening for Hereditary Thrombophilia

Because hereditary Protein S deficiency is an autosomal dominant genetic disorder caused by mutations in the PROS1 gene, it runs in families. If a close relative (parent, sibling, or child) has been diagnosed with a documented Protein S deficiency or has a history of severe, early-onset blood clots, a physician may recommend screening other family members. Identifying asymptomatic carriers allows for proactive counseling regarding high-risk situations, such as upcoming surgeries, long-distance travel, or pregnancy, where temporary preventive measures can be implemented.

Assessment of Unusual Site Thrombosis

While blood clots most commonly develop in the deep veins of the lower extremities, they can occasionally occur in atypical anatomical locations. These include the cerebral venous sinuses, mesenteric veins of the abdomen, portal vein, hepatic veins (Budd-Chiari syndrome), or renal veins. Thrombosis in these unusual sites strongly suggests an underlying systemic hypercoagulable state. A comprehensive thrombophilia workup, featuring the Protein-S test, is essential in these cases to uncover the driving pathology and guide complex therapeutic interventions.

Neonatal Purpura Fulminans Investigation

In extremely rare cases, a newborn may inherit two defective PROS1 genes (homozygous deficiency), resulting in a complete absence of functional Protein S. This manifests shortly after birth as neonatal purpura fulminans, a catastrophic and life-threatening condition characterized by widespread microvascular thrombosis, severe skin necrosis, and disseminated intravascular coagulation (DIC). Immediate, emergency testing of Protein S levels is vital to confirm this diagnosis, allowing for the rapid administration of fresh frozen plasma or specialized protein concentrates to save the infant’s life.

What Does a Protein-S Test Detect?

The Protein-S test is a highly sensitive diagnostic tool that can detect a wide spectrum of inherited and acquired conditions, physiological states, and therapeutic interferences. Specifically, the test is capable of detecting:

• Type I Congenital Protein S Deficiency: Characterized by a parallel reduction in total Protein S antigen, free Protein S antigen, and functional activity.
• Type II Congenital Protein S Deficiency: A qualitative defect where total and free antigen levels are normal, but the functional activity of the protein is significantly reduced.
• Type III Congenital Protein S Deficiency: Characterized by normal total Protein S levels but significantly decreased free antigen and reduced functional activity.
• Vitamin K Deficiency: Since Protein S requires vitamin K for post-translational gamma-carboxylation, a deficiency in this vitamin leads to the production of non-functional Protein S.
• Oral Anticoagulant Therapy Effects: Detects the suppressive effect of Warfarin and other vitamin K antagonists on hepatic synthesis of functional Protein S.
• Severe Liver Dysfunction: Because Protein S is synthesized in hepatocytes, advanced liver diseases like cirrhosis or hepatitis result in significantly reduced levels.
• Acute Thrombotic Consumption: Detects the temporary depletion of Protein S as it is actively consumed during an ongoing clotting event.
• Disseminated Intravascular Coagulation (DIC): Identifies the profound consumption of natural anticoagulants during widespread, uncontrolled systemic clotting.
• Estrogen-Induced Suppression: Detects the physiological down-regulation of Protein S caused by oral contraceptive use or hormone replacement therapy.
• Pregnancy-Related Depletion: Identifies the normal, progressive physiological decline in Protein S levels that occurs during gestation.
• Nephrotic Syndrome: Detects the loss of free Protein S through the kidneys due to glomerular filtration barrier impairment.
• Active Inflammatory States: Identifies decreased free Protein S levels caused by an increase in C4b-binding protein (an acute-phase reactant) which binds and inactivates free Protein S.
• Sepsis and Severe Infections: Detects acquired deficiencies caused by inflammatory cytokines suppressing Protein S synthesis and promoting consumption.
• Antiphospholipid Syndrome (APS) Interference: Identifies potential false-low activity results caused by lupus anticoagulants interfering with clot-based functional assays.
• Direct Oral Anticoagulant (DOAC) Interference: Detects falsely elevated or altered activity levels caused by the presence of medications like Rivaroxaban or Apixaban in the sample.
• Heparin Contamination: Identifies assay interference caused by therapeutic heparin or heparin flush contamination during blood draw.
• Pediatric Physiological Variations: Detects the naturally lower levels of Protein S found in healthy newborns and infants compared to adults.
• Sickle Cell Disease: Identifies chronic, low-grade activation of coagulation and acquired Protein S deficiency common in these patients.
• Inflammatory Bowel Disease (IBD): Detects acquired deficiencies associated with active Crohn’s disease or ulcerative colitis.
• Post-Operative Depletion: Identifies transient decreases in Protein S levels following major surgical procedures due to hemodilution and consumption.

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, we understand that timely results are crucial for managing clotting disorders and making critical clinical decisions. Because the Protein-S test is a specialized coagulation assay requiring precise pre-analytical handling, including centrifugation to obtain platelet-poor plasma and controlled incubation, the standard turnaround time is typically 24 to 48 hours. Once the analysis is complete, the results are meticulously reviewed and signed off by our consultant pathologists to ensure absolute accuracy. Patients are promptly notified via an automated SMS containing a secure link to download their digital report directly from our online portal. Physical copies of the report can also be collected from our main laboratory facility or any of our convenient collection centers across Lahore.

Protein-S Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Protein S Functional Activity	60% to 140% (may vary slightly by age and sex)	Decreased activity (<60%) indicating inherited or acquired deficiency; falsely elevated due to DOACs.
Free Protein S Antigen	Within established adult reference range (typically 65% to 140%)	Reduced levels indicating Type I or Type III deficiency, pregnancy, estrogen use, or liver disease.
Total Protein S Antigen	Within established adult reference range (typically 70% to 140%)	Reduced in Type I deficiency; normal in Type II and Type III deficiencies despite low activity.
Vitamin K Status	Normal dietary intake and absorption	Deficiency leading to non-functional Protein S and prolonged clotting times.
Liver Synthesis Capacity	Normal hepatic function and protein synthesis	Impaired synthesis due to cirrhosis, hepatitis, or liver failure, causing low Protein S.
C4b-Binding Protein (C4b-BP)	Normal levels (balanced binding of Protein S)	Elevated levels in acute inflammation, leading to a decrease in active free Protein S.
Anticoagulant Therapy Status	No active therapy or appropriate therapeutic range	Warfarin therapy causing marked decrease in functional Protein S; Heparin causing assay interference.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for Protein-S Test?

• Experienced healthcare professionals: Our team of highly qualified pathologists and laboratory technologists specialize in advanced hematology and coagulation diagnostics.
• Patient-focused care: We prioritize patient comfort and safety, ensuring a gentle, stress-free blood collection experience at all times.
• Quality diagnostic services: Lahore PCR Lab adheres to international standards of quality control, ensuring highly reproducible and clinically reliable results.
• Professional reporting: Every report undergoes a rigorous multi-step verification process by senior consultants before release.
• Modern diagnostic approach: We utilize state-of-the-art automated analyzers and molecular testing methodologies to deliver cutting-edge diagnostics.
• Comfortable environment: Our facilities in Lahore are designed to provide a clean, hygienic, and welcoming atmosphere for all patients.
• Convenient location: Strategically located in Lahore, our main lab and collection points are easily accessible, with home sample collection services also available.
• Commitment to accurate diagnosis: We are dedicated to providing precise diagnostic insights that empower physicians to make informed, life-saving clinical decisions.